Funding will deepen market presence, win enterprise clients, and scale AI Agent adoption across India, the Middle East, Latin America, and Africa

MUMBAI, India and SAN FRANCISCO, July 23, 2025 — Gupshup, the global Conversational AI leader, today announced it has raised over $60 million in a funding round combining equity and debt financing from Globespan Capital Partners and EvolutionX Debt Capital. The funding will fuel the expansion of its Conversational AI and messaging platform as well as accelerate go-to-market execution across high-growth markets, including India, the Middle East, Latin America, and Africa.

This latest investment validates Gupshup’s market leadership in helping businesses engage their customers through conversational AI experiences delivered via text messaging or voice. With 50,000+ customers in 130+ countries, Gupshup has consistently been recognized by industry analysts, including Gartner, IDC, and Juniper, for its outstanding AI capabilities and market leadership in the evolving Conversational AI landscape. Across marketing, sales, and support use cases, Gupshup is delivering measurable business impact such as substantially higher conversions and revenues, lower costs, and increased customer satisfaction.

The funding will be strategically deployed to enhance sales velocity, product innovation, and deepen market presence across key verticals, globally. Gupshup is experiencing unprecedented demand for its platform, driven by the AI transformation across the world.

“Gupshup has turned the vision of Conversational AI into an enterprise-scale reality. We’re proud to support their next phase of growth as they expand across emerging markets. With deep AI expertise, robust infrastructure, and relentless execution, Gupshup is redefining how businesses engage customers”, said Andy Goldfarb, Co-Founder and Managing Partner, Globespan Capital Partners. “From India to UAE, Saudi Arabia, and Brazil, Gupshup’s Conversation Cloud and AI Agents are transforming customer and employee interactions. As Meta’s Partner of the Year, they’re building the foundation for AI-powered messaging at scale.”

“Gupshup has been the market leader at every stage of industry evolution from basic messaging to conversational AI across text and voice, which has led to consistent revenue growth and margin expansion,” said Rahul Shah, Partner at EvolutionX Debt Capital. ” Gupshup is well-poised to lead the AI transformation worldwide, and we are excited to work with them and support them in this journey. With this investment, we continue our strategy of investing in category-leading growth stage companies in Asia“.

“We’re at an inflection point where AI Agents are transitioning from experimental technology to business-critical infrastructure, leading to extraordinary global demand for our solutions. Businesses recognize that conversational AI is driving enormous competitive advantages through superior customer experiences. This funding positions us to capture that global opportunity”, said Beerud Sheth, Founder and CEO, Gupshup.

The company’s platform enables businesses to automate complex customer interactions while maintaining personalized, human-like conversations. Through solutions like Conversational AI Agents, Click to Chat Ads, AI Campaign CoPilot, Agent Assist, Personalize, and Campaign Manager, businesses can handle everything from product discovery and purchasing to customer support and retention, representing a significant evolution from traditional chatbots to autonomous agents.

Gupshup’s platform already powers 120 Billion+ messages annually for thousands of enterprises, with advanced AI capabilities that position it as the comprehensive solution for businesses seeking to implement conversational engagement at scale.

Photo – https://mma.prnewswire.com/media/2735989/Gupshup_Technologies.jpg
Logo – https://mma.prnewswire.com/media/2182479/Gupshup_Logo.jpg

SOURCE Gupshup Technologies

The Banks Leverage the Power of the CRA to Build Clean Communities and the Manufacturing Jobs of the Future

LOS ANGELES, July 22, 2025 — The 22 Fund (“The 22”), a Los Angeles-based impact-focused, early-growth venture capital firm, today announced multi-million-dollar equity investments from BMO Bank N.A. (BMO) and City National Bank. BMO is investing $5 million and City National put $3 million into The 22’s recently closed approximately $42 million fund—capital sourced through each bank’s Community Reinvestment Act (CRA) initiatives.

“Helping to create economic opportunities is one way BMO lives its Purpose, to Boldly Grow the Good in business and life,” said Carl Jenkins, Managing Director and Group Head, Community Capital Solutions at BMO. “Our investment in The 22 Fund aligns with our CRA strategy to close funding gaps, create good jobs, and empower communities to thrive.”

“The 22 Fund’s mission aligns with City National’s CRA commitment of creating long-term economic opportunities,” added Adey Tesfaye, Senior Vice President – Head of CRA at City National Bank. “We are excited to back a venture model focused on export-oriented businesses that delivers measurable community outcome.” The CRA, a landmark piece of legislation enacted to address systemic disinvestment in low- and moderate-income (LMI) communities, has traditionally focused on affordable housing and community lending. However, The 22 Fund is pioneering a new pathway by channeling CRA-driven capital into venture investments that address climate change, create high-quality jobs, foster innovation, and promote inclusive economic development in underserved areas.

“The CRA is one of the most powerful tools we have for creating equitable economic outcomes in this country,” said Tracy D. Gray, Founder and Managing Partner of The 22 Fund. “We’re proud to be among a small but growing number of venture firms using CRA capital to support diverse founders and scale climate technology.”

The 22 invests in innovative, U.S.-based manufacturing companies with strong export potential and scalable business models. The fund intentionally aims to generate both financial returns and tangible socioeconomic impact without compromise. Each of the fund’s five current portfolio companies meets these inclusive criteria.

The 22 also welcomed Annie E. Casey Foundation, Sierra Club Foundation, Include Ventures and Heading for Change who joined as LPs in 2024. Each of these investors are leaders in impact and climate investing and leveraging their capital to build stronger communities.

The 22’s model uniquely qualifies under CRA guidelines by directly supporting the creation of the clean quality jobs of the future and improvement in LMI areas. With its targeted approach to inclusive climate tech manufacturing, The 22 delivers impactful, scalable outcomes that align with the CRA’s original intent.

About The 22 Fund
The 22 Fund is a holistic impact investor that funds tech-based, climate focused U.S. manufacturing companies to increase international sales (exports) and create the clean, quality jobs of the future in underserved and low- and moderate-income (LMI) communities. The 22 intentionally invests in women- and BIPOC-led firms to deliver both high ROI and high social/economic impact without concession or trade-offs. For more information, visit www.the22fund.com.

About BMO Financial Group
BMO Financial Group is the seventh largest bank in North America by assets, with total assets of $1.4 trillion as of April 30, 2025. Serving customers for 200 years and counting, BMO is a diverse team of highly engaged employees providing a broad range of personal and commercial banking, wealth management, global markets and investment banking products and services to 13 million customers across Canada, the United States, and in select markets globally. Driven by a single purpose, to Boldly Grow the Good in business and life, BMO is committed to driving positive change in the world, and making progress for a thriving economy, sustainable future, and inclusive society.

About City National Bank
City National Bank, a subsidiary of Royal Bank of Canada (RBC), is the largest bank headquartered in Los Angeles. Founded in 1954, City National is a regional bank specializing in Wealth Management and Private Banking, Entertainment & Sports Banking, Commercial Banking, and Consumer Banking, with branches and locations in Los Angeles, Orange County, San Diego, the San Francisco Bay Area, New York City, Nashville, Atlanta, Delaware, Las Vegas, Washington D.C. and Miami.* For more information about City National, visit the company’s website at cnb.com.

*City National Bank does business in Miami and the state of Florida as CN Bank.

Contact:

Vanessa Gray

[email protected]

SOURCE The 22 Fund

Led by Decibel with participation from Mayfield, Homebrew, and others, the company is powering the shift from traditional SEO to AI search optimization

SALT LAKE CITY, July 22, 2025 — Scrunch AI, the company helping brands understand and improve how they appear in AI search, today announced a $15 million Series A funding round led by Decibel, with participation from Mayfield, Homebrew, and other strategic investors.

The raise follows a period of rapid growth. Over the past three months alone, Scrunch has grown its paying customer base by more than 50% month-over-month. Today, over 500 brands utilize the platform to monitor and enhance their visibility in AI search results. Nearly all growth to date has come through inbound demand, with customers reporting an average 40% increase in referral traffic and up to 4x improvement in visibility across generative platforms.

In addition to its enterprise-grade solutions, Scrunch has also launched a dedicated offering for agencies, designed to help them guide their clients through the transition to AI search. This program provides tailored access, insights, and tools specifically built for managing multiple brands and implementing at scale.

“Your website doesn’t need to go away, but 90% of its human traffic will,” said Chris Andrew, co-founder and CEO of Scrunch AI. “AI agents are becoming the new front door to your brand, and we’re building the infrastructure that helps you show up, stand out, and stay ahead.

The way people discover brands is changing fast, and marketers are scrambling to catch up. We started Scrunch to provide brands with clarity on how they appear in AI search. That visibility is valuable in its own right, but it also gave us something more profound: a technical blueprint for how modern discovery actually works.”

Since launching, Scrunch has analyzed tens of millions of prompts and citations across leading generative platforms, building a data-rich understanding of how large language models interpret, rank, and surface content. Now, the company is leveraging that insight to enhance its monitoring capabilities and move toward delivery.

The newly raised capital will accelerate the development and deployment of the Scrunch Agent Experience Platform (AXP), a new infrastructure layer that helps brands serve optimized content directly to AI crawlers and agents.

Traditional websites designed for human browsers are often inefficient and ineffective for AI. AXP enables brands to maintain their existing websites for users while delivering compressed, structured, and machine-readable content specifically for AI engines, thereby improving discoverability and placement without requiring a redesign. AXP is currently in pilot with enterprise customers and will be rolled out more broadly in the months ahead.

“Scrunch has the unique advantage of having built the foundation first — collecting data, learning from real-world behavior, and shipping with speed,” said Jon Sakoda, Partner at Decibel. “They’re not just observing the AI shift. They’re helping brands rewrite the web for AI Agents.”

The generative search ecosystem is growing quickly, but most brands remain unprepared. More than 70% of Fortune 1000 websites are difficult or impossible for AI crawlers to interpret, and companies continue to spend billions on traditional search strategies misaligned with how discovery works today.

With a market opportunity estimated at over $100 billion, Scrunch is building for the next era of brand visibility, one optimized for how AI understands the internet.

“We believe the best marketers will be the ones who adapt first,” added Andrew. “Scrunch gives them the platform and technology to do exactly that.”

About Scrunch AI
Scrunch AI is an enterprise-grade platform that empowers businesses to understand and optimize their presence in AI search. The platform provides a comprehensive suite of tools to assess competitive positioning, pinpoint content gaps, and optimize websites for AI search and retrieval, ensuring brands remain relevant in the evolving AI landscape.

Scrunch is led by CEO Chris Andrew, a seasoned product leader with extensive experience in developing SaaS solutions. Since its inception, the company has secured $19 million in funding from Decibel, Mayfield, and Homebrew, as well as notable technologists TJ Parker (PillPack), Bryant Chou (WebFlow), and Clara Shih (Meta AI, previously Salesforce, Hearsay). For more information, visit www.scrunchai.com.

SOURCE Scrunch AI

Former Slack and Salesforce GC joins Ballistic to advise founders and focus on future innovation in a security landscape increasingly impacted by complex privacy, compliance and regulatory changes.

SAN FRANCISCO, July 22, 2025 — Ballistic Ventures, the venture capital firm dedicated exclusively to funding and incubating entrepreneurs and innovations in cybersecurity, today announced that David Schellhase has joined the firm as an Entrepreneur in Residence (EIR).

Schellhase brings over 25 years of legal and operational leadership with a track record of scaling high-growth technology companies and guiding them through pivotal transitions. He has served as General Counsel at six companies, including Salesforce and Groupon during their IPOs, and most recently at Slack Technologies, where he also led teams responsible for legal, privacy, corporate development, business development, public affairs, the Slack Fund, and Slack for Good. He led Slack through their IPO and their $28B sale to Salesforce. He also spent the past two years as Of Counsel at the law firm of Sullivan & Cromwell and co-taught a course last term in Stanford’s School of Management Science and Engineering. Additionally, he serves as an advisor to Airtable and Webflow.

“David’s extensive experience at the intersection of law, technology, and corporate strategy makes him a great addition to our team,” said Jake Seid, Co-founder and General Partner of Ballistic Ventures. “From companies to consumers, how privacy, compliance and regulation is dealt with is complex and burdensome. We see tremendous opportunities for innovation in these areas to ease that burden, and we’re excited for David to both support our companies and explore new ideas of his own.”

“Ballistic has built a rare platform for founders, combining deep expertise and a hands-on approach from inception to scale,” said Schellhase. “I’m excited to join as an Entrepreneur in Residence to support the next generation of security innovators and explore emerging challenges and opportunities.”

To learn more about the Ballistic team, visit https://ballisticventures.com/team/.

About Ballistic Ventures
Ballistic Ventures is a venture capital firm solely dedicated to early-stage cybersecurity and cyber-related companies. The partners have spent their entire careers defending against every cyber threat conceivable. Members of the firm have founded, operated, and funded over 100 successful cybersecurity firms – including Abnormal Security, AlienVault, ArcSight, Fortify, Mandiant, and Shape Security – led over 10,000 security professionals globally, and have 40+ years of experience in venture capital. The Ballistic portfolio includes Aembit, Alethea, ArmorCode, AuthMind, BreachRx, Codezero, Concentric AI, GetReal, Gomboc AI, Hypernative, Mimic, Noma, Nudge Security, Oligo, Pangea, Perygee, Reach, SpecterOps, Talon (PANW), Veza, WitnessAI, and Zip Security. Our experience provides entrepreneurs impactful support from people focused on the same mission. Our networks and relationships open doors for our founders. Learn more at ballisticventures.com.

SOURCE Ballistic Ventures

SAN DIEGO, July 22, 2025 — Cooler Heads, a pioneering medical device company, has closed an oversubscribed $11M Series A funding round to expand the manufacturing and rollout of Amma™, the only FDA-cleared Portable Scalp Cooling System. The Amma™ system helps chemotherapy patients keep their hair and preserve their privacy, eliminating the disfiguring hair loss that has long been an accepted side effect of chemotherapy.

“Hair loss is so emotionally devastating that 8% of patients eligible for chemotherapy refuse treatment.” said Kate Dilligan, breast cancer survivor, Founder, and CEO of Cooler Heads. “Amma™ is a user-friendly platform that helps infusion centers seamlessly add scalp cooling to their workflows. The American Medical Association’s decision to elevate scalp cooling reimbursement codes to Category I starting in January 2026 creates powerful momentum for us, reinforcing scalp cooling as an emerging standard of care.”

By cooling the scalp before, during, and after chemotherapy, Amma™ reduces blood flow to hair follicles, shielding them from chemotherapy drugs and therefore preventing hair loss. Amma™ offers a continuous cooling system that eliminates the need for dry ice or frequent cap changes, making it a more accessible alternative to traditional methods.

The Series A financing was led by Mutual Capital Partners, a Cleveland healthtech-focused venture capital fund, and contained participation from SHD Partners, Crescent Ridge VC, Cal Innovation Fund, NuFund, Robin Hood Ventures, Golden Seeds, HIP VC, and an unnamed strategic investor. Funds will be used to increase manufacturing capacity, expand the commercial team, and to develop the next generation of the product.

Investors see Amma™ as a game-changer in cancer care, with the potential to improve the quality of life for thousands of patients. “Our investment in Cooler Heads reflects our confidence in the ability of this leadership team to make scalp cooling available wherever patients are getting chemotherapy. Cooler Heads is not only improving care for patients, but for the first time making this therapy low friction for infusion centers,” said Liz Todia Zambory who led the Mutual Capital Partners team’s investment. In addition to Liz Todia Zambory, Mike Schotzinger of SHD Partners joined the company’s Board of Directors and Jason Pesterfield, the CEO of Elucent Medical, joined as an independent director.

For patients, Amma™ is more than just a device, it’s a source of hope and empowerment during treatment. “In a process where so much is stripped away, scalp cooling helped me keep a part of myself intact, and that gave me strength,” said Jennifer George, who used Amma during 16 cycles of chemotherapy while being treated for early stage breast cancer in 2024.

Contact:
press@coolerheads.com

About Cooler Heads:

Cooler Heads, based in San Diego, provides evidence-based products, content, and services that cancer patients need to manage the challenging side effects of treatment. Founded by a cancer survivor, Cooler Heads is driven by the mission to reduce the physical and emotional toll of cancer treatment, offering tools like Amma to improve the quality of life for patients.

About Mutual Capital Partners:

Mutual Capital Partners is a Cleveland, OH based venture capital firm helping innovative healthcare startups reach their full potential. Mutual Capital Partners invests in strong teams commercializing technologies that improve patient outcomes; either medical device or healthcare IT companies located outside the major tech centers.

SOURCE Cooler Heads Care, Inc.

• NUS will invest S$50 million (US$39 million) in selected venture capital (VC) firms to provide structured support for NUS tech start-ups.
• S$100 million will be committed to an autonomous investment fund focused on NUS-affiliated start-ups, with the flexibility to invest alongside selected VC partners.

SINGAPORE, July 22, 2025 — Asia is grappling with a prolonged funding winter, with venture capital investments falling sharply to a 10-year low of S$85 billion (US$66 billion). With a five per cent decline from 2023, early-stage funding totalled less than S$38 billion (US$29 billion) in 2024^[1]. To address the critical funding and mentorship gaps faced by tech start-ups, NUS Enterprise, the entrepreneurial arm of the National University of Singapore (NUS) — flagship comprehensive research university in Singapore, is committing S$150 million (US$116 million) to launch the NUS VC Programme.

The initiative aims to enhance support for early-stage tech innovation by focusing on high-potential ventures within the NUS ecosystem, including start-ups from the National Graduate Research Innovation Programme (National GRIP). National GRIP empowers innovators to transform lab-based research discoveries into globally competitive, market-ready ventures.

“As the region faces a sharp pullback in venture capital activity, we see the new NUS VC Programme — the first of its kind initiative by a university in Asia — as a critical enabler. Research-based start-ups face distinct challenges, including R&D cycles that are much longer than traditional start-ups, making them especially vulnerable in today’s cautious investment environment. This programme brings together capital, strategic partnerships, and specialised venture expertise to create a more resilient path from lab to market,” said Professor Tan Eng Chye, NUS President.

Beyond capital: Money and expertise

The programme comprises two key components.

First, NUS will commit S$50 million (US$39 million) over the next three years in selected venture capital firms with strong track records in early-stage deep tech investments. These firms will provide structured, hands-on support to start-ups, including time, expertise, and access to their networks to help them scale effectively.

The first two VC partners are Granite Asia, a leading multi-asset investment platform with a 25-year track record of backing breakthrough technology ventures globally, and 4BIO Capital, a specialist life sciences investor focused on advanced therapeutics. (Refer to Annexes A and B for details on the structured initiatives developed by NUS in collaboration with these partners and their quotes.)

Second, NUS will set aside S$100 million (US$78 million) for co-investments alongside these VC partners. These co-investments will be targeted at NUS-affiliated start-ups.

Complementing National GRIP with expert VC support for NUS start-ups

Many National GRIP start-ups are still in the early stages of technological readiness and require continued, strategic support to advance from lab to market. The NUS VC Programme complements the National GRIP framework by addressing this need for downstream venture development. While GRIP currently provides up to S$250,000 (US$194,000) in seed funding per start-up, the VC Programme focuses on accelerating post-seed growth and preparing ventures for external capital.

What sets this effort apart is the direct engagement with leading venture capital firms selected not only for their track records, but also for their market access in global innovation hubs. By combining capital with deep venture expertise, the programme offers structured support including mentorship, investor feedback, market entry, fundraising networks, and operational guidance.

“National GRIP is an important first step in helping deep tech start-ups take root,” said Dr Tan Sian Wee, NUS Senior Vice President (Innovation & Enterprise). “The VC Programme builds on this by pairing promising ventures with globally connected investors, enabling a more complete pathway to scale and commercial success. This is essential given that most start-ups struggle to move beyond early-stage innovation toward impactful, real-world deployment.”

For media enquiries, please contact:

For NUS Enterprise (APRW on behalf of NUS Enterprise):
Aye Mya Mya Toe (Mya)
+65 9237 4813
[email protected]

Bijal Doshi
+65 9754 7691
[email protected]

SOURCE NUS Enterprise

Raising Series B Related Funding to $59M

REDMOND, Wash., July 22, 2025 — Lumotive, the pioneer in programmable optical semiconductor technology, today announced investments from Amazon Industrial Innovation Fund and ITHCA Group. The investments will help Lumotive to rapidly accelerate product deployments in industrial applications and enhance its global market presence.

The Amazon Industrial Innovation Fund backs technologies that advance automation, robotics, and next-generation industrial systems. Its support of Lumotive signals confidence in the company’s game-changing approach— replacing bulky mechanical optical components with a fully digital, reconfigurable semiconductor. Lumotive’s LCM™ platform enables a new era of intelligent perception systems that are compact, software-defined, and essential for the factories, robots, and logistics networks of the future. With Amazon’s backing, Lumotive joins a select group of transformative companies shaping the future of automation and industrial AI.

“We invest in breakthrough technologies that redefine what’s possible—and Lumotive is doing  just that,” said Franziska Bossart, Director, Amazon Industrial Innovation Fund. “With their programmable optical beamforming chips, Lumotive is building a critical foundation for the next generation of intelligent machines. We’re excited to support their mission and see broad potential for their technology in industrial automation, robotics, and beyond.”

Additionally, the investment from ITHCA Group, Oman’s sovereign tech fund, reflects a strategic alignment with Lumotive’s breakthrough technology and the country’s digital transformation goals. As Oman accelerates smart infrastructure and AI initiatives, Lumotive’s entry into the region positions both sides to benefit from regional momentum and global innovation.

“This strategic investment reflects our confidence in Lumotive’s world-class technology and its potential impact on the region,” said Said bin Abdullah Al Mandhari, CEO of ITHCA Group. “Lumotive’s presence in Oman strengthens our innovation ecosystem and supports national priorities across telecommunications, AI, and smart infrastructure. We’re proud to welcome Lumotive to our growing portfolio of future-focused companies.”

“These investments reinforce the transformational potential of our programmable optical semiconductor platform,” said Dr. Sam Heidari, CEO of Lumotive. “As global industries embrace software-defined automation, Lumotive is uniquely positioned to deliver the intelligent sensing solutions needed for the future of robotics, logistics, and manufacturing. This funding fuels our mission to scale rapidly and lead this new wave of innovation.”

The investments by Amazon and ITHCA Group, together with financing by Stifel Bank, expand the company’s Series B-related funding and add to previous investments from EDOM, East Bridge, Gates Frontier, Grazia, HiMax, Hokuyo, MetaVC Partners, Quan Funds, Swisscom Ventures, and TSVC. As adoption of its optical semiconductor platform accelerates, Lumotive is positioned to power the next generation of applications across automation, mobility, smart infrastructure, and beyond.

About Lumotive 
Lumotive is pioneering the era of programmable optics—where light is controlled as intelligently and flexibly as software.

Our patented Light Control Metasurface (LCM™) transforms photonics into a digital platform, unlocking breakthroughs in sensing, optical switching, and communication. Today, LCM technology is powering a new generation of solid-state Lidar systems—compact, software-defined, and high-performance solutions for autonomy, robotics, and smart infrastructure. With more than 200 patents and growing commercial traction, Lumotive is delivering the world’s first digital platform for light—and redefining what’s possible in the optical age. Headquartered in Redmond, Washington, Lumotive is backed by leading investors including Gates Frontier, MetaVC Partners, Quan Funds, Swisscom Ventures, Samsung Ventures, Amazon Industrial Innovation Fund, and ITHCA. For more information, visit www.lumotive.com.

Contact: David Wamsley, [email protected]

SOURCE Lumotive

The global project leverages Viam’s AI technology to transform how nuclear waste is managed over time

NEW YORK, July 22, 2025 — Viam, the engineering platform for data, AI and automation, today announced a partnership with Swiss nuclear engineering company Transmutex. Viam’s platform supports Transmutex in building robust and enduring ion source systems that break down nuclear waste.

Transmutex is focused on transforming long-lived radioactive waste into shorter-lived isotopes, addressing a critical challenge in nuclear waste management. While ion sources are critical to nuclear waste transmutation, they are typically optimized for performance rather than longevity. When an ion source shut offs unexpectedly, it can take up to 5 days to restart fully. Reducing these shut downs requires collecting detailed data from a complex network of sensors and leveraging AI/ML to identify root causes.

Viam provides the infrastructure to capture this data and build AI models that can pinpoint error sources in real time. The insights gained can quickly diagnose hardware failures and identify optimization opportunities, allowing Transmutex to quickly get reliable ion sources back up and running.

“Transmutex is working to combat one of the most complex challenges in the nuclear energy sector,” said Viam Founder and CEO Eliot Horowitz. “Our work together demonstrates Viam’s ability to drive actionable insights within even the most complex of systems.” 

Transmutex’s project is supported by a $4.2 million grant from the U.S. Department of Energy’s ARPA-E under the NEWTON program. The Geneva, Switzerland-based Transmutex was founded in 2019 by former CERN physicists and focuses on advancing technologies for nuclear waste transmutation, including accelerator-driven systems (ADS) and fast neutron reactors, which promise safer, more efficient waste management.

“To solve major challenges around nuclear waste, we need advanced technology that can help build enduring ion sources,” said Franklin Servan-Schreiber, Co-Founder and CEO of Transmutex. “Viam exists at the intersection of data and AI, allowing us to access a level of real-time visibility that is essential for our operations.” 

Viam’s platform helps companies add cutting-edge capabilities to existing systems and build new ones fast by integrating AI, robotics, data and automation. The company was launched in 2020 by Eliot Horowitz, former co-founder and CTO of MongoDB. Earlier this year, Viam closed a Series C funding round led by Union Square Ventures.

About Viam
Viam helps companies unlock the power of AI, data and automation in the physical world. We provide a single platform for engineers of all disciplines to solve problems together and build solutions that are fast and future-proof. Viam powers solutions across robotics, food and beverage, climate tech, marine, industrial manufacturing, and more. Founded in 2020 by former MongoDB co-founder and CTO Eliot Horowitz, Viam is headquartered in New York City. viam.com

About Transmutex
Transmutex is pioneering a unique accelerator driven subcritical transmutation technology and providing a comprehensive solution to the burden of long-lived, highly radioactive nuclear waste. Conceived at Los Alamos National Laboratory and demonstrated at CERN, our proprietary technology dramatically reduces the lifetime of nuclear waste from up to one million years to approximately 500 years, while also decreasing required storage volume by more than 5x times.  Transmuting high level nuclear waste also produces essential rare industrial metals, life-saving medical isotopes and genuinely green energy while breeding fuel that enables energy sovereignty. Founded in 2019 with headquarters in Switzerland, Transmutex has established deep collaborations with top-tier research institutions while securing backing from leading venture capital partners. transmutex.com

Media Contacts:

Christopher Farrell
Beginners
[email protected]

SOURCE Viam, Inc.

HUNTINGTON, N.Y., July 22, 2025 — Sen-Jam Pharmaceuticals today announced the launch of the Healthspan Catalyst Fund—introducing two powerful new pathways for individuals and institutions to support and participate in the company’s mission to radically transform how inflammation-driven diseases are prevented and treated. Inflammation, the silent culprit behind 75% of chronic conditions, is a primary driver of America’s declining healthspan. Sen-Jam’s breakthrough platform uniquely targets all five pathways of inflammation, leapfrogging traditional biotech to deliver low-cost, fast-tracked solutions that treat further upstream, mitigating disease before it takes root.

With this initiative, Sen-Jam is not only accelerating science, but also revolutionizing access—opening the door for both legacy philanthropists and everyday investors to engage in the upside of early-stage biotech innovation.

Supporters now have two ways to join the movement:

1. Philanthropic Giving through CataCap – Foundations, Donor-Advised Funds (DAFs), and individual philanthropists can make tax-deductible contributions or program-related investments (PRIs) via CataCap, a 501(c)(3) intermediary administered by ImpactAssets.
2. Community Investing on Wefunder – Accredited and non-accredited investors alike may invest in Sen-Jam’s anti-inflammatory portfolio through a Regulation CF round on Wefunder (minimum investment: $250).

“Whether you’re a philanthropist focused on public-health impact or an investor seeking participation in our upside, we now have an on-ramp for everyone,” said Jim Iversen, Co- Founder & CEO of Sen-Jam Pharmaceuticals. “Together, we can compress the timeline between drug discovery and patient benefit and usher in a new era upending sickcare to celebrate longer, healthier lives.“

Launch Goal: $25,000 by August 8, 2025

Achieving this target will activate Sen-Jam’s public listing on the CataCap platform, unlocking a broader universe of mission-aligned donors and matching opportunities.
Use of Funds All proceeds—philanthropic and investment—will fuel pre-clinical and clinical research on inflammation-driven, age-related diseases and advance Sen-Jam’s lead clinical programs, including the Phase 2 trial for SJP-001 (Alcohol related Inflammation).

How to Participate
Tax-Deductible Path: Make a contribution or PRI via CataCap
Investment Path: Review offering documents and invest on Wefunder

About Sen-Jam Pharmaceutical
Sen-Jam Pharmaceutical is a clinical-stage biopharmaceutical company pioneering pleiotropic anti-inflammatory regulators (PAIR technology) to address conditions ranging from alcohol hangover to chronic metabolic disease. The company has over 60 patents across 23 countries and partners with leading institutions including Duke University, the National Institute on Drug Abuse, and KVK-Tech.

Media &Investor Contact
Christine Leonard, Director of Strategic Communications
[email protected] • 781-913-1902

Forward-Looking Statement Disclaimer: This press release contains forward-looking statements involving risks and uncertainties. Actual results may differ materially. Equity investments are speculative and not insured; review all offering materials before investing.

SOURCE Sen-Jam Pharmaceutical